Ekso Bionics (EKSO) announced that it has named Bionic Prosthetics & Orthotics Group, a leading national provider of prosthetic and orthotic solutions, as a non-exclusive Ekso Indego Personal device distributor. “This exciting new commercial alliance with a recognized leader like Bionic P&O aligns squarely with our mission of improving health and quality of life with advanced robotics designed to enhance, amplify, and restore human function,” commented Scott Davis, the Company’s Chief Executive Officer.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EKSO:
- EKSO Earnings this Week: How Will it Perform?
- Ekso Bionics files to sell 10.5M shares of common stock for holders
- Ekso Bionics’ Earnings Call: Growth Amid Challenges
- Ekso Bionics price target lowered to $1 from $2 at Lake Street
- Ekso Bionics: Strategic Partnerships and Financial Health Drive Buy Rating with $9 Price Target